InSite teams with IBM for data center

Article

Xoft prepares brachytherapy product for Canada

InSite teams with IBM for data center

InSite One is purchasing IBM storage and servers for its primary data center in Connecticut. Over the next three to five years, the company expects to replace and expand its existing storage and servers there to more than 1 petabyte. IBM will supply IBM System x Servers and DS3200 Storage systems. The total value of the agreement is pegged at more than $15 million. The two companies will also collaborate on client enterprise storage and archiving opportunities in which InSite One sells services and IBM sells storage and infrastructure solutions.

Xoft prepares brachytherapy product for Canada

Regulators in Canada have granted a medical device license for the sale in that country of Xoft's Axxent Electronic Brachytherapy System. The system delivers localized, nonradioactive, isotope-free radiation treatment in minimally shielded clinical settings. It has been commercially available in the U.S. since 2006 under an FDA clearance for the treatment of early stage breast cancer, endometrial cancer, and skin and surface indications.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.